Quick Answer
Curanex Pharmaceuticals Inc reported Stockholders Equity of $11.22 million for the year ending 2025.
- Curanex Pharmaceuticals Inc showed an increase of +2,128.8% in Stockholders Equity from 2024 to 2025.
- This data is from Curanex Pharmaceuticals Inc's annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2024: $129.9 thousand | Q2 2024: $715.2 thousand | Q3 2024: $624.2 thousand | Q1 2025: $365.8 thousand | Q2 2025: $305.4 thousand | Q3 2025: $14.29 million.
- Over the full 3 years of available data (2023 to 2025), Curanex Pharmaceuticals Inc's Stockholders Equity has grown by 18,570.5%.
- Historical annual values: Fiscal year 2025: $11.22 million | Fiscal year 2024: $503.4 thousand | Fiscal year 2023: $60.1 thousand.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: